Eosinophil granule proteins as a biomarker in managing asthma and allergies

被引:10
作者
Kim, Chang-Keun [1 ]
Callaway, Zak [1 ,3 ]
Pawankar, Ruby [2 ]
机构
[1] Inje Univ, Sanggye Paik Hosp, Asthma & Allergy Ctr, Dept Pediat, Seoul, South Korea
[2] Nippon Med Sch, Dept Pediat, Tokyo, Japan
[3] Inje Univ, Sanggye Paik Hosp, Asthma & Allergy Ctr, 760-1 Sanggye 7 Dong, Seoul 139707, South Korea
关键词
Allergic disease; biomarker; children; eosinophil; eosinophil-derived neurotoxin; SYNCYTIAL VIRUS BRONCHIOLITIS; ATOPIC-DERMATITIS; BIOLOGICAL-PROPERTIES; CATIONIC PROTEIN; DISEASE SEVERITY; NEUROTOXIN; VALIDATION; EXACERBATIONS; QUESTIONNAIRE; INFLAMMATION;
D O I
10.5415/apallergy.0000000000000104
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
In the past few decades, biomarkers have been successfully used for the diagnosis, treatment, and monitoring of disease. Taking together clinical, genetic, lifestyle, and information on relevant biomarkers, the therapy of diseases can be personalized to an individual. Several novel biomarkers have been recently reported for allergic diseases. However, to interpret the validity of biomarker data, the validation of their reliability, precision, and reproducibility is imperative. Once validated, they can be used in therapeutic product development and in clinical practice. Eosinophils are multifunctional leukocytes and major effector cells that play a crucial role in the immunological mechanisms of allergic disease. Measuring eosinophils has been the gold standard for treating and monitoring eosinophil-related diseases such as asthma, atopic dermatitis, and allergic rhinitis. However, eosinophil numbers/percentages yield little information about eosinophil activity. Eosinophil activation leads to the extracellular release of 4 granule proteins, with the most promising biomarker of the 4 being eosinophil-derived neurotoxin (EDN). EDN is more easily recovered from measuring instruments and cell surfaces than other eosinophil biomarkers because of its weaker electrical charge. EDN is known to be released from eosinophils at a greater efficiency, adding to its recoverability. It also has antiviral activity in respiratory infections associated with allergic disease development in early life (eg, respiratory syncytial virus and human rhinovirus infections in early childhood). EDN can be measured in several body fluids, including blood, urine, sputum, nasal secretions, and bronchoalveolar lavage. EDN is a stable biomarker utilized to precisely diagnose, treat, and monitor many eosinophil-related allergic diseases. This eosinophil granule protein may prove useful in precision medicine approaches and should always be considered as a useful tool for the clinician to give the best patient care possible.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 68 条
[1]   Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics [J].
Agache, I. ;
Strasser, D. S. ;
Klenk, A. ;
Agache, C. ;
Farine, H. ;
Ciobanu, C. ;
Groenen, P. M. A. ;
Akdis, C. A. .
ALLERGY, 2016, 71 (08) :1192-1202
[2]   Intranasal Corticosteroid Administration Reduces Nonspecific Bronchial Hyperresponsiveness and Improves Asthma Symptoms [J].
Agondi, Rosana Camara ;
Machado, Maria Lavinea ;
Kalil, Jorge ;
Giavina-Bianchi, Pedro .
JOURNAL OF ASTHMA, 2008, 45 (09) :754-757
[3]   Consensus statements, evidence-based medicine and guidelines in allergic diseases [J].
Bousquet, J. ;
Bieber, T. ;
Fokkens, W. ;
Humbert, M. ;
Kowalski, M. L. ;
Niggemann, B. ;
Simon, H. -U. ;
Schuenemann, H. .
ALLERGY, 2008, 63 (01) :1-4
[4]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[5]   Biomarker definitions and their applications [J].
Califf, Robert M. .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 243 (03) :213-221
[6]   Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age [J].
Caudri, Daan ;
Wijga, Alet ;
Schipper, C. Maarten A. ;
Hoekstra, Maarten ;
Postma, Dirkje S. ;
Koppelman, Gerard H. ;
Brunekreef, Bert ;
Smit, Henriette A. ;
de Jongste, Johan C. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (05) :903-910
[7]   Validation of childhood asthma predictive tools: A systematic review [J].
Colicino, Silvia ;
Munblit, Daniel ;
Minelli, Cosetta ;
Custovic, Adnan ;
Cullinan, Paul .
CLINICAL AND EXPERIMENTAL ALLERGY, 2019, 49 (04) :410-418
[8]   A computational framework for complex disease stratification from multiple large-scale datasets [J].
De Meulder, Bertrand ;
Lefaudeux, Diane ;
Bansal, Aruna T. ;
Mazein, Alexander ;
Chaiboonchoe, Amphun ;
Ahmed, Hassan ;
Balaur, Irina ;
Saqi, Mansoor ;
Pellet, Johann ;
Ballereau, Stephane ;
Lemonnier, Nathanael ;
Sun, Kai ;
Pandis, Ioannis ;
Yang, Xian ;
Batuwitage, Manohara ;
Kretsos, Kosmas ;
van Eyll, Jonathan ;
Bedding, Alun ;
Davison, Timothy ;
Dodson, Paul ;
Larminie, Christopher ;
Postle, Anthony ;
Corfield, Julie ;
Djukanovic, Ratko ;
Chung, Kian Fan ;
Adcock, Ian M. ;
Guo, Yi-Ke ;
Sterk, Peter J. ;
Manta, Alexander ;
Rowe, Anthony ;
Baribaud, Frederic ;
Auffray, Charles .
BMC SYSTEMS BIOLOGY, 2018, 12
[9]   Toward clinically applicable biomarkers for asthma: An EAACI position paper [J].
Diamant, Zuzana ;
Vijverberg, Susanne ;
Alving, Kjell ;
Bakirtas, Arzu ;
Bjermer, Leif ;
Custovic, Adnan ;
Dahlen, Sven-Erik ;
Gaga, Mina ;
van Wijk, Roy Gerth ;
Del Giacco, Stefano ;
Hamelmann, Eckard ;
Heaney, Liam G. ;
Heffler, Enrico ;
Kalayci, Omer ;
Kostikas, Konstantinos ;
Lutter, Rene ;
Olin, Anna-Carin ;
Sergejeva, Svetlana ;
Simpson, Angela ;
Sterk, Peter J. ;
Tufvesson, Ellen ;
Agache, Ioana ;
Seys, Sven F. .
ALLERGY, 2019, 74 (10) :1835-1851
[10]  
Diny NL., 2017, Front Immunol, V214, P943